R2103588 |
SX682 |
SX-682 is an orally bioavailable, potent allosteric inhibitor of CXCR1 and CXCR2
|
R2103589 |
Mli-2 |
MLi-2 is an orally active and highly selective LRRK2 inhibitor with an IC50 of 0
|
R2103591 |
PT-2399 |
PT2399 is a potent and selective HIF-2α antagonist, which directly binds to HIF-
|
R2103592 |
(Rac)-PT2399 |
(Rac)-PT2399 (Compound 10e), the racemate of PT2399, acts as a potent and specif
|
R2103593 |
EGFR-IN-7 (compound 34) |
EGFR-IN-7 (compound 34) is a selective and potent EGFR kinase inhibitor extracte
|
R2103594 |
MSAB |
MSAB is a potent and selective inhibitor of Wnt/β-catenin signaling. MSAB binds
|
R2103595 |
Rogaratinib;BAY1163877 |
Rogaratinib is a potent and selective fibroblast growth factor receptor (FGFR) i
|
R2103553 |
Omadacycline hydrochloride (PTK0796 hydrochloride) |
Omadacycline hydrochloride is novel, aminomethyl tetracycline antibiotic being d
|
R2103590 |
MYF-01-37 |
MYF-01-37 is a novel covalent inhibitor of TEAD.
|
R2103596 |
PQR530 |
PQR530 is a potent, ATP-competitive, orally bioavailable and brain-penetrant dua
|
R2103597 |
CD38 inhibitor 1 |
CD38 inhibitor 1 (compound 78c) is a potent CD38 inhibitor with IC50s of 7.3 nM
|
R2103598 |
Olutasidenib |
Olutasidenib (FT-2102) is a highly potent, orally active, brain penetrant and se
|
R2103599 |
PRN1008 |
PRN1008 is a reversible covalent, selective and oral active inhibitor of Bruton’
|
R2103600 |
Allopregnanolone |
Allopregnanolone, a neurosteroid synthesized from progesterone in brain, acts as
|
R2103601 |
SEP-363856 (SEP-856) hydrochloride |
SEP-363856 hydrochloride(SEP-856 hydrochloride), an orally active and CNS active
|
R2123602 |
ML251 |
2-(3,4-Dichlorophenyl)-N-[4-(1,2-oxazol-3-ylsulfamoyl)phenyl]acetamide
|
R2123603 |
ML267 |
4-(3-Chloro-5-(trifluoromethyl)pyridin-2-yl)-N-(4-methoxypyridin-2-yl)piperazine
|
R2123604 |
methyl 4-acetamido-2-(2-bromoethoxy)-5-chlorobenzoate |
methyl 4-acetamido-2-(2-bromoethoxy)-5-chlorobenzoate
|
R2123605 |
Ceftolozane sulfate |
5-amino-2-(((6R,7R)-7-((Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(((2-carboxypropa
|
R2123606 |
CU-CPT-9a |
CU-CPT-9a is a specific TLR8 antagonist, with an IC50 of 0.5 nM.
|
R2123607 |
ASLAN003 |
ASLAN003 is an orally active and potent Dihydroorotate Dehydrogenase (DHODH) inh
|
R2123608 |
MF438 |
MF-438 is a potent and orally bioavailable stearoyl-CoA desaturase 1 (SCD1) inhi
|
R2123609 |
Calpain Inhibitor IV;IN1508 |
benzyl N-[1-[[1-[[4-fluoro-1-(4-hydroxyphenyl)-3-oxobutan-2-yl]amino]-4-methyl-1
|
R2123610 |
OGT-IN-2 |
Ogt-in-2 is an o-GLCNAC transferase (OGT) inhibitor with IC50 of 53 M.Ogt-in-2 d
|
R2123611 |
HM30181;HM30181A;Encequidar; |
Encequidar (HM30181; HM30181A) is a potent and selective inhibitor of P-glycopro
|